fomesafen has been researched along with Osteosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, RM; Hieble, JP; Jaworski, JP; Jin, J; Laping, NJ; Lashinger, ES; Leon, LA; Morrow, DM; Su, X; Wu, CW | 1 |
GEORGE, P; JAMES, DH | 1 |
2 other study(ies) available for fomesafen and Osteosarcoma
Article | Year |
---|---|
Modulation of bladder function by prostaglandin EP3 receptors in the central nervous system.
Topics: Acrylamides; Animals; Cell Line, Tumor; Central Nervous System; CHO Cells; Cricetinae; Cricetulus; Dinoprostone; Female; Humans; Injections, Intraventricular; Injections, Spinal; Kidney; Muscle Contraction; Nociceptors; Osteosarcoma; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Reflex; Sulfones; Transfection; Tritium; Urinary Bladder; Urination | 2008 |
VINCRISTINE IN CHILDREN WITH MALIGNANT SOLID TUMORS.
Topics: Adolescent; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Fibrosarcoma; Hodgkin Disease; Humans; Infant; Lymphoma, Non-Hodgkin; Neoplasms; Nervous System; Neuroblastoma; Osteosarcoma; Radiography; Reflex; Reflex, Abnormal; Retinoblastoma; Sarcoma; Sarcoma, Ewing; Teratoma; Toxicology; Vincristine; Wilms Tumor | 1964 |